Eosinofili--patogenese, klassifikation og behandling

Christen Lykkegaard Andersen; Hanne Vestergaard; Peter Nørgaard; Peter Felding; Niels Pallisgaard; Inge Hellegaard Rasmussen; Hans Carl Hasselbalch; Ole Weis Bjerrum

Eosinofili--patogenese, klassifikation og behandling

Christen Lykkegaard Andersen
, Hanne Vestergaard
, Peter Nørgaard
, Peter Felding
, Niels Pallisgaard
, Inge Hellegaard Rasmussen
, Hans Carl Hasselbalch
, Ole Weis Bjerrum

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

Eosinophilia represents a complex clinical problem, the management of which is based on case history and clinical examination. Allergy, parasitic infection or inflammation may then be identified or malignancy suspected. In some cases, representing a haematologic disorder, clonality is demonstrated only by specific tests. The diagnostic and therapeutic approach, including a new classification for eosinophilia, is reviewed, and the importance of molecular biological technique is highlighted. Unexplained eosinophilia should be managed in collaboration with a haematology department.
Udgivelsesdato: 2009-Nov-2

Bidragets oversatte titel	Eosinophilia--pathogenesis, classification and therapy
Originalsprog	Dansk
Tidsskrift	Ugeskrift for Læger
Vol/bind	171
Udgave nummer	45
Sider (fra-til)	3256-62
Antal sider	6
ISSN	0041-5782
Status	Udgivet - 2. nov. 2009

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{13b759b0fe9c11deaefb000ea68e967b,

title = "Eosinofili--patogenese, klassifikation og behandling",

abstract = "Eosinophilia represents a complex clinical problem, the management of which is based on case history and clinical examination. Allergy, parasitic infection or inflammation may then be identified or malignancy suspected. In some cases, representing a haematologic disorder, clonality is demonstrated only by specific tests. The diagnostic and therapeutic approach, including a new classification for eosinophilia, is reviewed, and the importance of molecular biological technique is highlighted. Unexplained eosinophilia should be managed in collaboration with a haematology department. Udgivelsesdato: 2009-Nov-2",

keywords = "Bone Marrow, Diagnosis, Differential, Eosinophilia, Humans, Hypereosinophilic Syndrome, Molecular Diagnostic Techniques, Risk Factors",

author = "Andersen, \{Christen Lykkegaard\} and Hanne Vestergaard and Peter N{\o}rgaard and Peter Felding and Niels Pallisgaard and Rasmussen, \{Inge Hellegaard\} and Hasselbalch, \{Hans Carl\} and Bjerrum, \{Ole Weis\}",

year = "2009",

month = nov,

day = "2",

language = "Dansk",

volume = "171",

pages = "3256--62",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "L{\ae}geforeningen",

number = "45",

}

TY - JOUR

T1 - Eosinofili--patogenese, klassifikation og behandling

AU - Andersen, Christen Lykkegaard

AU - Vestergaard, Hanne

AU - Nørgaard, Peter

AU - Felding, Peter

AU - Pallisgaard, Niels

AU - Rasmussen, Inge Hellegaard

AU - Hasselbalch, Hans Carl

AU - Bjerrum, Ole Weis

PY - 2009/11/2

Y1 - 2009/11/2

N2 - Eosinophilia represents a complex clinical problem, the management of which is based on case history and clinical examination. Allergy, parasitic infection or inflammation may then be identified or malignancy suspected. In some cases, representing a haematologic disorder, clonality is demonstrated only by specific tests. The diagnostic and therapeutic approach, including a new classification for eosinophilia, is reviewed, and the importance of molecular biological technique is highlighted. Unexplained eosinophilia should be managed in collaboration with a haematology department. Udgivelsesdato: 2009-Nov-2

AB - Eosinophilia represents a complex clinical problem, the management of which is based on case history and clinical examination. Allergy, parasitic infection or inflammation may then be identified or malignancy suspected. In some cases, representing a haematologic disorder, clonality is demonstrated only by specific tests. The diagnostic and therapeutic approach, including a new classification for eosinophilia, is reviewed, and the importance of molecular biological technique is highlighted. Unexplained eosinophilia should be managed in collaboration with a haematology department. Udgivelsesdato: 2009-Nov-2

KW - Bone Marrow

KW - Diagnosis, Differential

KW - Eosinophilia

KW - Humans

KW - Hypereosinophilic Syndrome

KW - Molecular Diagnostic Techniques

KW - Risk Factors

M3 - Tidsskriftartikel

C2 - 19887055

SN - 0041-5782

VL - 171

SP - 3256

EP - 3262

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

IS - 45

ER -